Clinical trial
The Role of CD4+T Lymphocyte Subsets in Cell Immunity in Patients With Sepsis
NCT01494389 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of CD4+T Lymphocyte Subsets in Cell Immunity in Patients With Sepsis
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- March 31, 2012
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, sirs(systemic inflammatory response syndrome)